InvestorsHub Logo
Followers 4
Posts 480
Boards Moderated 0
Alias Born 09/18/2017

Re: None

Wednesday, 02/07/2018 8:01:47 AM

Wednesday, February 07, 2018 8:01:47 AM

Post# of 70
The Athenex factory – supported by a $200 million grant from New York state – will be dedicated to manufacturing cancer therapies developed by Athenex and other companies(DCTH?). 

Athenex said in its last conference call that it hopes to break ground on the factory by April 2018, and has also reported previously that work is expected to take place in two phases. The larger first phase will include the main 281,180-square-foot facility to include high-tech manufacturing space, warehousing and offices/labs, with an expected completion date of 2019. A second phase will involve a 39,000-square-foot expansion for manufacturing and offices/labs, with an estimated completion date of 2020. 

Athenex's deal with New York state also included its "North American headquarters" in the Conventus building on the Buffalo Niagara Medical Campus, where the state spent $25 million to support office space and a pilot factory. The company has said it is roughly doubling the size of its factory in Newstead to 40,000 square feet. It is also developing two manufacturing facilities in China. 



https://www.bizjournals.com/buffalo/news/2018/01/09/athenex-signs-general-contractor-for-320-000.html ;
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.